Heart Failure

Latest News

Prognostic Implications of NT-proBNP Levels in Heart Failure With AF

Higher NT-proBNP levels have less prognostic importance in patients with HFpEF and AF than in those without.

Influenza Activity Associated With Heart Failure Hospitalization Risk

Influenza activity was linked to increased heart failure hospitalizations in 4 influenza seasons.

Empagliflozin Reduces Risk for Heart Failure Hospitalizations in Real-World Study

Boehringer Ingelheim and Lilly announced preliminary data from the EMPRISE ( EMPagliflozin compaRative effectIveness and SafEty) real-world study at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2019 in San Diego.

Effects of Transitional Care Services on Heart Failure Outcomes

Additional transitional care services do not improve outcomes for heart failure patients discharged from the hospital.

How Does Microvascular Disease Affect Heart Failure Risk in Type 2 Diabetes?

Presence of microvascular disease in patients with both type 2 diabetes and cardiovascular disease increases the risk for heart failure and hospitalization for heart failure.

FDA Approves New Device for Chronic, Moderate-to-Severe Heart Failure

Optimizer Smart system approved for patients with chronic heart failure not eligible for tx with other devices.

Trastuzumab Tied to Higher Long-Term Risk for Heart Failure

Increased risk for heart failure seen in breast cancer survivors given trastuzumab rather than chemo alone.

SGLT2 Inhibitors Reduce Heart Failure Risk in T2D With Reduced EF

Real-world data indicate that lower risk of heart failure hospitalization and death associated with use of sodium-glucose cotransporter-2 inhibitors is consistent in patients with T2D with both reduced and preserved ejection fraction.

Endogenous Testosterone Linked to Cardiovascular Disease

Genetically predicted endogenous testosterone may have role in thromboembolism, heart failure, MI.

Diuretic Use Differences Examined in HFrEF Treated With Sacubitril/Valsartan, Enalapril

For patients with HFrEF, treatment with sacubitril/valsartan may aid in reducing the requirement for loop diuretics compared with enalapril.